Engineering the
Future of Health
At Helvica, innovation isn't a department. It's our DNA. We are pushing the boundaries of biotechnology and AI-driven drug discovery.
$4.2B
Annual R&D Invest
120+
Clinical Trials
3,500+
Active Patents
12
Research Centers
Core Technologies
Genomic Sequencing
Precision medicine tailored to individual genetic profiles.
AI Drug Discovery
Machine learning algorithms identifying novel molecular structures.
Nanotherapeutics
Targeted delivery systems that minimize side effects.
